Johnson & Johnson »

Rapport Therapeutics shares owned by Johnson & Johnson

Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by Johnson & Johnson from 13F filings

Historical chart of Johnson & Johnson investment in Rapport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapport Therapeutics held by Johnson & Johnson consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapport Therapeutics by Johnson & Johnson

Quarter filed Position value Share count Share price at filing
2025-09-30 $53M 1.8M 29.70
2025-06-30 $29M 2.5M 11.43
2025-03-31 $25M 2.5M 10.03
2024-12-31 $44M 2.5M 17.74
2024-09-30 $51M 2.5M 20.48
2024-06-30 $58M 2.5M 23.26